HEADER CARBOHYDRATE 23-FEB-21 7NML TITLE GALECTIN-1 IN COMPLEX WITH 4-AMINO-6-CHLORO-1,3-BENZENEDISULFONAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALECTIN-1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GAL-1,14 KDA LAMININ-BINDING PROTEIN,HLBP14,14 KDA LECTIN, COMPND 5 BETA-GALACTOSIDE-BINDING LECTIN L-14-I,GALAPTIN,HBL,HPL,LACTOSE- COMPND 6 BINDING LECTIN 1,LECTIN GALACTOSIDE-BINDING SOLUBLE 1,PUTATIVE MAPK- COMPND 7 ACTIVATING PROTEIN PM12,S-LAC LECTIN 1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LGALS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS GALECTIN-1, CARBOHYDRATE EXPDTA X-RAY DIFFRACTION AUTHOR C.GRIMM,J.BECHOLD,J.SEIBEL REVDAT 2 31-JAN-24 7NML 1 REMARK REVDAT 1 02-MAR-22 7NML 0 JRNL AUTH C.GRIMM,J.BECHOLD,J.SEIBEL JRNL TITL GALECTIN-1 IN COMPLEX WITH JRNL TITL 2 4-AMINO-6-CHLORO-1,3-BENZENEDISULFONAMIDE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.43 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.43 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 52083 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.030 REMARK 3 FREE R VALUE TEST SET COUNT : 2100 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.4000 - 3.5300 0.99 3640 154 0.1744 0.2005 REMARK 3 2 3.5300 - 2.8000 0.99 3462 145 0.1646 0.1687 REMARK 3 3 2.8000 - 2.4500 0.99 3423 144 0.1667 0.2136 REMARK 3 4 2.4400 - 2.2200 0.98 3372 141 0.1499 0.2158 REMARK 3 5 2.2200 - 2.0600 0.98 3363 142 0.1299 0.1629 REMARK 3 6 2.0600 - 1.9400 0.98 3373 141 0.1331 0.1744 REMARK 3 7 1.9400 - 1.8400 0.98 3317 140 0.1394 0.2006 REMARK 3 8 1.8400 - 1.7600 0.98 3326 139 0.1620 0.2245 REMARK 3 9 1.7600 - 1.7000 0.97 3286 138 0.1852 0.2403 REMARK 3 10 1.7000 - 1.6400 0.97 3288 138 0.2200 0.2896 REMARK 3 11 1.6400 - 1.5900 0.97 3246 137 0.2524 0.3131 REMARK 3 12 1.5900 - 1.5400 0.96 3236 136 0.2688 0.2950 REMARK 3 13 1.5400 - 1.5000 0.97 3261 137 0.3002 0.3743 REMARK 3 14 1.5000 - 1.4600 0.96 3255 137 0.3336 0.3531 REMARK 3 15 1.4600 - 1.4300 0.93 3135 131 0.3823 0.3972 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.187 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.620 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.61 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 2247 REMARK 3 ANGLE : 1.100 3052 REMARK 3 CHIRALITY : 0.108 325 REMARK 3 PLANARITY : 0.006 409 REMARK 3 DIHEDRAL : 19.417 822 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7NML COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1292114199. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-FEB-18 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52116 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.430 REMARK 200 RESOLUTION RANGE LOW (A) : 40.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 6.560 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.1700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.43 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.48 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4Q26 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 287K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.65950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.02000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.23750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.02000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.65950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.23750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 134 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 320 O HOH A 379 1.97 REMARK 500 O HOH A 417 O HOH A 418 1.97 REMARK 500 O HOH B 351 O HOH B 410 1.98 REMARK 500 O HOH A 358 O HOH A 407 2.05 REMARK 500 O HOH B 410 O HOH B 417 2.08 REMARK 500 O HOH A 380 O HOH A 408 2.12 REMARK 500 O HOH A 319 O HOH A 413 2.14 REMARK 500 O HOH A 369 O HOH A 416 2.16 REMARK 500 O HOH B 391 O HOH B 414 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 400 O HOH B 391 1545 1.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 87 CG1 - CB - CG2 ANGL. DEV. = 10.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 50 93.51 -162.95 REMARK 500 PRO A 78 52.92 -93.60 REMARK 500 ASN A 113 50.44 -117.01 REMARK 500 ASP A 125 54.06 -91.83 REMARK 500 PHE A 133 75.29 -116.92 REMARK 500 PRO B 78 49.91 -93.36 REMARK 500 REMARK 500 REMARK: NULL DBREF 7NML A 2 134 UNP P09382 LEG1_HUMAN 3 135 DBREF 7NML B 2 134 UNP P09382 LEG1_HUMAN 3 135 SEQRES 1 A 133 CYS GLY LEU VAL ALA SER ASN LEU ASN LEU LYS PRO GLY SEQRES 2 A 133 GLU CME LEU ARG VAL ARG GLY GLU VAL ALA PRO ASP ALA SEQRES 3 A 133 LYS SER PHE VAL LEU ASN LEU GLY LYS ASP SER ASN ASN SEQRES 4 A 133 LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN ALA HIS GLY SEQRES 5 A 133 ASP ALA ASN THR ILE VAL CYS ASN SER LYS ASP GLY GLY SEQRES 6 A 133 ALA TRP GLY THR GLU GLN ARG GLU ALA VAL PHE PRO PHE SEQRES 7 A 133 GLN PRO GLY SER VAL ALA GLU VAL CME ILE THR PHE ASP SEQRES 8 A 133 GLN ALA ASN LEU THR VAL LYS LEU PRO ASP GLY TYR GLU SEQRES 9 A 133 PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU ALA ILE ASN SEQRES 10 A 133 TYR MET ALA ALA ASP GLY ASP PHE LYS ILE LYS CME VAL SEQRES 11 A 133 ALA PHE ASP SEQRES 1 B 133 CYS GLY LEU VAL ALA SER ASN LEU ASN LEU LYS PRO GLY SEQRES 2 B 133 GLU CME LEU ARG VAL ARG GLY GLU VAL ALA PRO ASP ALA SEQRES 3 B 133 LYS SER PHE VAL LEU ASN LEU GLY LYS ASP SER ASN ASN SEQRES 4 B 133 LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN ALA HIS GLY SEQRES 5 B 133 ASP ALA ASN THR ILE VAL CYS ASN SER LYS ASP GLY GLY SEQRES 6 B 133 ALA TRP GLY THR GLU GLN ARG GLU ALA VAL PHE PRO PHE SEQRES 7 B 133 GLN PRO GLY SER VAL ALA GLU VAL CME ILE THR PHE ASP SEQRES 8 B 133 GLN ALA ASN LEU THR VAL LYS LEU PRO ASP GLY TYR GLU SEQRES 9 B 133 PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU ALA ILE ASN SEQRES 10 B 133 TYR MET ALA ALA ASP GLY ASP PHE LYS ILE LYS CME VAL SEQRES 11 B 133 ALA PHE ASP MODRES 7NML CME A 16 CYS MODIFIED RESIDUE MODRES 7NML CME A 88 CYS MODIFIED RESIDUE MODRES 7NML CME A 130 CYS MODIFIED RESIDUE MODRES 7NML CME B 16 CYS MODIFIED RESIDUE MODRES 7NML CME B 88 CYS MODIFIED RESIDUE MODRES 7NML CME B 130 CYS MODIFIED RESIDUE HET CME A 16 18 HET CME A 88 18 HET CME A 130 18 HET CME B 16 18 HET CME B 88 17 HET CME B 130 18 HET DMS A 201 4 HET I7B B 201 26 HET DMS B 202 4 HET DMS B 203 4 HET DMS B 204 4 HET DMS B 205 4 HET DMS B 206 4 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM DMS DIMETHYL SULFOXIDE HETNAM I7B 4-AMINO-6-CHLOROBENZENE-1,3-DISULFONAMIDE FORMUL 1 CME 6(C5 H11 N O3 S2) FORMUL 3 DMS 6(C2 H6 O S) FORMUL 4 I7B C6 H8 CL N3 O4 S2 FORMUL 10 HOH *242(H2 O) HELIX 1 AA1 PRO A 101 GLY A 103 5 3 HELIX 2 AA2 PRO B 101 GLY B 103 5 3 SHEET 1 AA112 ALA A 67 TRP A 68 0 SHEET 2 AA112 ASP A 54 ASP A 64 -1 N ASP A 64 O ALA A 67 SHEET 3 AA112 ASN A 40 ALA A 51 -1 N ARG A 48 O THR A 57 SHEET 4 AA112 PHE A 30 ASP A 37 -1 N LEU A 34 O LEU A 43 SHEET 5 AA112 ILE A 117 GLY A 124 -1 O ALA A 121 N ASN A 33 SHEET 6 AA112 VAL A 5 LEU A 11 -1 N ALA A 6 O MET A 120 SHEET 7 AA112 VAL B 5 LEU B 11 -1 O SER B 7 N VAL A 5 SHEET 8 AA112 ILE B 117 GLY B 124 -1 O MET B 120 N ALA B 6 SHEET 9 AA112 PHE B 30 ASP B 37 -1 N ASN B 33 O ALA B 121 SHEET 10 AA112 ASN B 40 ALA B 51 -1 O LEU B 43 N LEU B 34 SHEET 11 AA112 ASP B 54 ASP B 64 -1 O THR B 57 N ARG B 48 SHEET 12 AA112 ALA B 67 TRP B 68 -1 O ALA B 67 N ASP B 64 SHEET 1 AA212 GLN A 72 ARG A 73 0 SHEET 2 AA212 ASP A 54 ASP A 64 -1 N CYS A 60 O GLN A 72 SHEET 3 AA212 ASN A 40 ALA A 51 -1 N ARG A 48 O THR A 57 SHEET 4 AA212 PHE A 30 ASP A 37 -1 N LEU A 34 O LEU A 43 SHEET 5 AA212 ILE A 117 GLY A 124 -1 O ALA A 121 N ASN A 33 SHEET 6 AA212 VAL A 5 LEU A 11 -1 N ALA A 6 O MET A 120 SHEET 7 AA212 VAL B 5 LEU B 11 -1 O SER B 7 N VAL A 5 SHEET 8 AA212 ILE B 117 GLY B 124 -1 O MET B 120 N ALA B 6 SHEET 9 AA212 PHE B 30 ASP B 37 -1 N ASN B 33 O ALA B 121 SHEET 10 AA212 ASN B 40 ALA B 51 -1 O LEU B 43 N LEU B 34 SHEET 11 AA212 ASP B 54 ASP B 64 -1 O THR B 57 N ARG B 48 SHEET 12 AA212 GLN B 72 ARG B 73 -1 O GLN B 72 N CYS B 60 SHEET 1 AA310 GLU A 105 PRO A 109 0 SHEET 2 AA310 ASN A 95 LYS A 99 -1 N LEU A 96 O PHE A 108 SHEET 3 AA310 SER A 83 PHE A 91 -1 N THR A 90 O THR A 97 SHEET 4 AA310 LEU A 17 VAL A 23 -1 N VAL A 23 O SER A 83 SHEET 5 AA310 PHE A 126 PHE A 133 -1 O LYS A 129 N ARG A 20 SHEET 6 AA310 PHE B 126 ALA B 132 -1 O LYS B 129 N PHE A 133 SHEET 7 AA310 LEU B 17 VAL B 23 -1 N ARG B 20 O LYS B 129 SHEET 8 AA310 SER B 83 PHE B 91 -1 O SER B 83 N VAL B 23 SHEET 9 AA310 ASN B 95 LYS B 99 -1 O LYS B 99 N CME B 88 SHEET 10 AA310 GLU B 105 PRO B 109 -1 O PHE B 108 N LEU B 96 LINK C GLU A 15 N CME A 16 1555 1555 1.33 LINK C CME A 16 N LEU A 17 1555 1555 1.32 LINK C AVAL A 87 N CME A 88 1555 1555 1.33 LINK C BVAL A 87 N CME A 88 1555 1555 1.34 LINK C CME A 88 N ILE A 89 1555 1555 1.33 LINK C LYS A 129 N CME A 130 1555 1555 1.32 LINK C CME A 130 N VAL A 131 1555 1555 1.35 LINK C GLU B 15 N CME B 16 1555 1555 1.33 LINK C CME B 16 N LEU B 17 1555 1555 1.33 LINK C VAL B 87 N CME B 88 1555 1555 1.33 LINK C CME B 88 N ILE B 89 1555 1555 1.32 LINK C LYS B 129 N CME B 130 1555 1555 1.34 LINK C CME B 130 N AVAL B 131 1555 1555 1.33 LINK C CME B 130 N BVAL B 131 1555 1555 1.33 CRYST1 43.319 58.475 112.040 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023085 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017101 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008925 0.00000